Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-021643

Chief Financial Officer bought 4,500 shares at $8.56 ($38,520)

From the SEC's structured data for this filing

Trades in this filing

WEAVER GREGORY L · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-03-23 Purchase : show line 1 in the form +4,500 $8.56 $38,520 4,500 D
Open-market purchases · 4,500 sh · avg $8.56 · $38,520
Loading xslF345X03/doc4.xml…